Deficits in auditory processing are a characteristic of schizophrenia. These have been formally demonstrated using a sensory gating paradigm in which surface auditory evoked potentials (AEPs) are measured in response to the presentation of closely paired clicks. Schizophrenics, unlike normal controls, show little or no inhibitory gating of a midlatency wave, P50, to the second click. The synaptic pathways and neurobiological mechanisms which are responsible for normal sensory gating, or the deficit seen in schizophrenia, are not known. Further, these circuits and mechanisms cannot be investigated in human subjects, due to the invasive nature of the anatomical and physiological technique involved. While there is no animal model of schizophrenia, there is a significant amount of evidence that the hippocampus is a site of pathology in this disease. We also have preliminary evidence for a hippocampal AEP in rats, N50, which has many features in common with human P50. The purpose of this project is to determine how auditory input reaches the hippocampus and how it is gated there. The results of this work will not definitively demonstrate which neuronal mechanisms are responsible for the gating of human P50, but they will indicate possible directions for further investigation in other projects in the Center. In collaboration with Project 4, we will explore the electrophysiology of sensory gating in nonhuman primates to validate our findings in a more """"""""advanced"""""""" brain. In collaboration with Project 5, we will isolate relevant circuits in intraocular transplants made from fetal rat tissue. This work will guide subsequent experiments in Project 5 which will involve transplantation of human fetal tissues.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH044212-04
Application #
3845825
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Miller, Christine L; Murakami, Peter; Ruczinski, Ingo et al. (2009) Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder. Schizophr Res 113:259-67
Stephens, Sarah H; Logel, Judith; Barton, Amanda et al. (2009) Association of the 5'-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia. Schizophr Res 109:102-12
Tregellas, Jason R; Davalos, Deana B; Rojas, Donald C et al. (2007) Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia. Schizophr Res 92:262-72
Stevens, K E; O'Neill, H C; Rose, G M et al. (2006) The 5-HT(1A) receptor active compounds (R)-8-OH-DPAT and (S)-UH-301 modulate auditory evoked EEG responses in rats. Amino Acids 31:365-75
Buhler, A V; Dunwiddie, T V (2001) Regulation of the activity of hippocampal stratum oriens interneurons by alpha7 nicotinic acetylcholine receptors. Neuroscience 106:55-67
Adler, L E; Olincy, A; Cawthra, E et al. (2001) Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism. Neuropsychopharmacology 24:671-9
Ross, R G; Olincy, A; Zerbe, G et al. (2001) Which duration of postsaccadic slowing identifies anticipatory saccades during smooth pursuit eye movements? Psychophysiology 38:325-33
Adams, C E; Stevens, K E; Kem, W R et al. (2000) Inhibition of nitric oxide synthase prevents alpha 7 nicotinic receptor-mediated restoration of inhibitory auditory gating in rat hippocampus. Brain Res 877:235-44
Ross, R G; Harris, J G; Olincy, A et al. (2000) Eye movement task measures inhibition and spatial working memory in adults with schizophrenia, ADHD, and a normal comparison group. Psychiatry Res 95:35-42
Weiland, S; Bertrand, D; Leonard, S (2000) Neuronal nicotinic acetylcholine receptors: from the gene to the disease. Behav Brain Res 113:43-56

Showing the most recent 10 out of 112 publications